Search | Ayema

added article Other

2024-09-23 09:22:55 -

US Multiple Sclerosis Drugs Market Statistical Spectrum: Unveiling Segmentation, Outlook, and Overview Trends | 2024-2030

The US Multiple Sclerosis Drugs Market size was valued at USD 10.52 Bn. in 2023 and the total US Multiple Sclerosis Drugs revenue is expected to grow at a CAGR of 2.1% from 2024 to 2030, reaching nearly USD 12.17 Bn. in 2030. US Multiple Sclerosis Drugs Market Overviews Stellar Market Research is an US Multiple Sclerosis DrugsMarket research company, that has published a...

0 Comments 0 Shares 400 Views 0 Reviews